Results 111 to 120 of about 1,268 (176)

Case report: Efgartigimod combined with intravenous methylprednisolone in a case of co-occurrence of unexplained myasthenia gravis, inflammatory myopathy, and fulminant myocarditis. [PDF]

Front Immunol
Yang H, Pan Z, Yang Y, Wang Y, Cheng B, Qi G.   +5 more
europepmc   +1 more source

Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia Gravis. [PDF]

Adv Ther
Jacob S, Hashim M, Hutton B, Gandhi K, Van Sanden S, Slowik R, Drudge C, Khoury ACE, Keng MJ, Singh S, Ramchandren S, Gilhus NE.   +11 more
europepmc   +1 more source

Clinical outcomes, serum IgG changes, and follow-up observations in the treatment of anti-AChR antibody-positive generalized myasthenia gravis with Efgartigimod. [PDF]

BMC Neurol
Fu J, Zheng X, Ma X, Qu Q, Cui W, Mao X, Fu W, Lyv H.   +7 more
europepmc   +1 more source

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study. [PDF]

J Neurol
Lin J, Chang T, Xiao L, Hu J, Di L, Yang C, Wu Y, Jiang Y, Zhang J, Bu B, Li Z.   +10 more
europepmc   +1 more source

Efgartigimod in Patients with Generalized Myasthenia Gravis Refractory or Intolerant to IVIg. [PDF]

Neurol Ther
D'Amico F, Campo S, Rini N, Vinciguerra C, Bevilacqua L, Erra C, Barone P, Tuccillo F, Habetswallner F, Brighina F, Di Stefano V.   +10 more
europepmc   +1 more source

Clinical heterogeneity and treatment optimization in anti-KLHL11 encephalitis: two case reports and literature review. [PDF]

Front Immunol
Han L, Li Y, Li C, Li L, Yao D, Hao Y, Zhou X, Dang Y, Zhang R, Gao L, Luo J, Yang J, Du Y, Zhang W.   +13 more
europepmc   +1 more source

Assessing the Value Contribution of Vyvgart^® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis. [PDF]

Adv Ther
Cortés-Vicente E, Guerrero A, Díaz C, Martínez E, Toja-Camba FJ, Abad MR, Serra JM, Trillo JL, Martín Machín C, Gil A.   +9 more
europepmc   +1 more source

Recurrent steroid-intolerant Hashimoto's encephalopathy responsive to single-dose neonatal Fc receptor antagonist: a case report and literature review. [PDF]

BMC Neurol
Wang X, Wang G, Xu J, Bai Y, Yan W, Liu X, Zhang S, Shen R.   +7 more
europepmc   +1 more source